Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)
China flag China · Delayed Price · Currency is CNY
17.28
+0.31 (1.83%)
Jun 3, 2025, 2:45 PM CST

SHE:002755 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2015 - 2019
Operating Revenue
1,8011,7411,4301,8593,0413,719
Upgrade
Other Revenue
37.0537.0513.7713.6165.2263.37
Upgrade
Revenue
1,8381,7781,4431,8733,1073,783
Upgrade
Revenue Growth (YoY)
18.30%23.15%-22.92%-39.72%-17.87%-16.29%
Upgrade
Cost of Revenue
340.63333.53277.51245.7277.05311.44
Upgrade
Gross Profit
1,4971,4441,1661,6272,8303,471
Upgrade
Selling, General & Admin
1,1821,151973.241,3332,1592,439
Upgrade
Research & Development
172.82177.32472.01588.84324.45255.89
Upgrade
Other Operating Expenses
25.8121.8315.6724.8941.1951.99
Upgrade
Operating Expenses
1,3821,3501,4561,9402,5202,739
Upgrade
Operating Income
114.7594.55-290.49-313.2309.73732.55
Upgrade
Interest Expense
-2.43-2.64-2.81-2.76-3.99-2.96
Upgrade
Interest & Investment Income
28.2530.9926.7839.8943.7236.58
Upgrade
Currency Exchange Gain (Loss)
1.371.370.960.07-0.02-0.06
Upgrade
Other Non Operating Income (Expenses)
-3.22-1.8-3.19-1.89-0.08-1.77
Upgrade
EBT Excluding Unusual Items
138.71122.46-268.75-277.89349.36764.35
Upgrade
Gain (Loss) on Sale of Investments
14.6312.7312.51.682.39-
Upgrade
Gain (Loss) on Sale of Assets
-0.16-0.030.030.210.3-0.02
Upgrade
Asset Writedown
-3.48-3.06-5.7-20.79-0.86-0.26
Upgrade
Other Unusual Items
24.7219.3560.9934.2954.8757.14
Upgrade
Pretax Income
174.43151.45-200.93-262.5406.07821.2
Upgrade
Income Tax Expense
21.3622.986.553.725.5195.83
Upgrade
Earnings From Continuing Operations
153.07128.47-207.48-266.21380.56725.37
Upgrade
Minority Interest in Earnings
30.4131.8258.9540.38-0.66-3.74
Upgrade
Net Income
183.48160.29-148.53-225.83379.91721.63
Upgrade
Net Income to Common
183.48160.29-148.53-225.83379.91721.63
Upgrade
Net Income Growth
-----47.35%-7.60%
Upgrade
Shares Outstanding (Basic)
908943928941927925
Upgrade
Shares Outstanding (Diluted)
908943928941927925
Upgrade
Shares Change (YoY)
-4.03%1.57%-1.34%1.55%0.16%-0.49%
Upgrade
EPS (Basic)
0.200.17-0.16-0.240.410.78
Upgrade
EPS (Diluted)
0.200.17-0.16-0.240.410.78
Upgrade
EPS Growth
-----47.44%-7.14%
Upgrade
Free Cash Flow
196.44180.94-155.89-203.27433.95380.7
Upgrade
Free Cash Flow Per Share
0.220.19-0.17-0.220.470.41
Upgrade
Dividend Per Share
0.1200.120--0.1000.200
Upgrade
Dividend Growth
-----50.00%-9.09%
Upgrade
Gross Margin
81.46%81.24%80.77%86.88%91.08%91.77%
Upgrade
Operating Margin
6.24%5.32%-20.13%-16.73%9.97%19.37%
Upgrade
Profit Margin
9.98%9.02%-10.29%-12.06%12.23%19.08%
Upgrade
Free Cash Flow Margin
10.69%10.18%-10.80%-10.85%13.97%10.06%
Upgrade
EBITDA
188.45169.84-208.79-224.03401.33825.17
Upgrade
EBITDA Margin
10.26%9.55%-14.46%-11.96%12.92%21.81%
Upgrade
D&A For EBITDA
73.775.381.789.1791.692.62
Upgrade
EBIT
114.7594.55-290.49-313.2309.73732.55
Upgrade
EBIT Margin
6.24%5.32%-20.12%-16.73%9.97%19.37%
Upgrade
Effective Tax Rate
12.25%15.17%--6.28%11.67%
Upgrade
Revenue as Reported
1,8381,7781,4431,8733,1073,783
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.